Loading organizations...
Key people at Longwall Ventures.
Longwall Ventures operates as a venture capital firm, strategically investing in early-stage deep technology businesses. The firm focuses on companies that harness the UK's advanced expertise in scientific research and development, aiming to translate innovative solutions into commercially viable ventures. It specializes in supporting the growth of these enterprises from their foundational stages, providing capital and strategic guidance to advance their technical innovations.
The firm was founded in 2011 by David Denny, Matthew Frohn, and Michael Penington. Their collective insight centered on identifying and nurturing nascent deep technology companies emerging from the UK's robust scientific ecosystem. This foundational vision aimed to bridge the gap between groundbreaking academic research and market-ready products, leveraging the founders' experience in venture capital and technology.
Longwall Ventures backs companies developing solutions across various deeptech sectors. Its portfolio companies are typically those striving to address significant global challenges through scientific and engineering breakthroughs. The firm's overarching vision is to foster the development of transformative technologies that will shape the future and provide lasting impact on a global scale.
Key people at Longwall Ventures.
Longwall Ventures has 8 tracked investments across 7 companies. The latest tracked deal is $24.0M Other Equity in Biofidelity in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 3, 2024 | Biofidelity | $24.0M Other Equity | — | TAD Weems, BlueYard Capital, Octopus Ventures |
| Aug 18, 2023 | Lightcast Discovery | $49.0M Series B | M Ventures | ARCH Venture Partners, Illumina Ventures, NanoDimension, OMX Ventures |
| Apr 1, 2023 | Caristo Diagnostics | $16.0M Series A | Heather Roxborough | Optum Ventures, BGF, Oxford Investment Consultants, Oxford University |
| Mar 2, 2022 | Helio Display Materials | $4.7M Series A | BGF, Longwall Ventures | — |
| Nov 3, 2021 | Closed Loop Medicine | $17.8M Series A | Lennart Hergel, TIM REA | Cambridge Angels, Matt Pierce, IQ Capital, Clare Terlouw, Meltwind |
| Aug 20, 2020 | Biofidelity | $12.0M Series A | Ciarán O'Leary | Agilent Technologies |
| Feb 24, 2016 | User Replay | $5.0M Grant / Other Equity | — | EC1 Capital, Innovate UK, The FSE Group |
| Mar 6, 2015 | Oxford PV | $12.1M Series B | — | MTI Partners, Parkwalk Advisors, University OF Oxford |